Five Years of Experience with Mitral Valve Homografts

Abstract

Introduction: The main advantages of mitral homografts are preservation of the subvalvular apparatus and avoidance of life-long anticoagulation. In this communication, we will present our five-year experience using mitral homografts in mitral valve surgery. Patients and Methods: Since 1996, 14 patients (mean age 46 ± 8 years, range 27 - 65 years have had mitral homografts implanted. Thirteen patients had mitral valve replacement; the septal leaflet of the tricuspid valve was replaced in one case. The indications were mitral (n = 6) or tricuspid endocarditis (n = 1), mitral valve stenosis (n = 3), and combined mitral valve disease (n = 4). Complete mitral homografts were implanted in eight patients; partial homografts were used in six cases. Preoperatively, the dimensions of the left ventricle and the mitral valve were measured by transoesophageal echocardiography (TOE). The mean left ventricular ejection fraction was 56 ± 9 %, the mean end-diastolic diameter 58 ± 6 mm. The technique described by Acar/Carpentier was adapted for implantation; a Carpentier ring was implanted in all cases for annular stabilization. The patients had anticoagulative therapy which was discontinued when stable sinus rhythm was present after three months postoperatively. Follow-up included clinical examination, ECG, and echocardiography, and was initiated six months postoperatively and continued on a yearly basis. The following parameters were determined by echocardiography - left atrial size, left ventricular end-diastolic and end-systolic diameter, pressure gradient across the mitral valve (c/w Doppler, Bernoulli's equation), and mitral regurgitation. Results: All patients survived surgery; the mean operation-time was 281 ± 37 minutes. Intraoperative TOE revealed a first degree insufficiency in 7 patients. Follow-up was completed in all patients, with a mean period of 30 months (6 - 60 months). Two patients had an acute endocarditis two years postoperatively, requiring repeat valve replacement with a mechanical prosthesis. An additional patient had to be reoperated due to chordal rupture three years postoperatively. All three patients had mitral valve stenosis as the initial indication for surgery and had received a complete homograft. In the remaining eleven patients, the morphological and functional state of the implanted grafts remained unchanged during follow-up. The freedom from valve-related events was 93 % after one year, 86 % after two years, and 79 % after three years. At six-month follow-up, ECG and echocardiography revealed sinus rhythm and sufficient atrial contractions in 13 cases. At the last follow-up, the pressure gradients were 3.4 ± 0.6 mmHg for complete homografts and 2.8 ± 0.6 mmHg for partial homografts. In five cases, a mild insufficiency was documented, while six patients presented with competent grafts. Conclusions: Mitral homografts can be used with acceptable mid-term results in selected cases with good left ventricular function and only slightly dilated left ventricles. Partial mitral homografts represent an additional technique, especially for mitral valve repair in patients with acute endocarditis. The susceptibility to bacterial infections of a homograft makes strict prophylaxis against endocarditis mandatory.

Key words

Homografts - Mitral valve replacement - Mitral valve endocarditis - Mitral valve repair

References

• 1 Vetter H, Nerlich A, Welsch U. et al . Total replacement of the mitral apparatus with a stentless, chordally supported mitral valve allograft: an experimental study.  J Thorac Cardiovasc Surg. 1996;  111 595-604
• 2 Vetter H O, Erhorn A, Fontaine A A, Reichart B, Yoganathan A P. Hemodynamic and echocardiographic characteristics of a stentless allograft mitral prosthesis: an in vitro study.  Cardiovasc Surg. 1996;  4 237-240
• 3 Vetter H O, Dagge A, Liao K. et al . Mitral allograft with chordal support: echocardiographic evaluation in sheep.  J Heart Valve Dis. 1995;  4 35-39
• 4 Acar C, Tolan M, Berrebi A. et al . Homograft replacement of the mitral valve. Graft selection, technique of implantation, and results of forty-three patients.  J Thorac Cardiovasc Surg. 1996;  111 367-378
• 5 Acar C, Farge A, Ramsheyi A. et al . Mitral valve replacement using a cryopreserved mitral homograft.  Ann Thorac Surg. 1994;  57 746-748
• 6 Acar C, Gaer J, Chauvaud S, Carpentier A. Technique of homograft replacement of the mitral valve.  J Heart Valve Dis. 1995;  4 31-34
• 7 Acar C, Berrebi A, Tolan M, Chaques J C. Partial mitral homograft: a new technique for mitral valve repair.  J Heart Valve Dis. 1995;  4 665-667
• 8 Acar C. The mitral homograft - is it worthwhile? (Editorial).  J Thorac Cardiovasc Surg. 2000;  120 448-449
• 9 Gulbins H, Kreuzer E, Uhlig A, Reichart B. Mitral valve surgery utilising homografts: Early results.  J Heart Valve Dis. 2000;  9 222-229
• 10 Kumar A S, Choudhary S K, Mathur A, Saxena A, Roy R, Chopra P. Homograft mitral valve replacement: five years' results.  J Thorac Cardiovasc Surg. 2000;  120 450-458
• 11 Dossche K, Vanermen H, Wellens F. Partial mitral valve replacement with a mitral homograft in subacute endocarditis.  Thorac Cardiovasc Surgeon. 1994;  42 240-242
• 12 Hyass U, Baron F, Fourchy D, Pansard Y. Mitral homografts for total tricuspid valve replacement: comparison of two techniques.  J Thorac Cardiovasc Surg. 2001;  121 592-594
• 13 Miyaaishima R T, Brumwell M L, Eric Jamieson W R, Munt B I. Tricuspid valve replacement using a cryopreserved mitral homograft. Surgical technique and initial results.  J Heart Valve Dis. 2000;  9 805-808
• 14 Katsumata T, Westaby S. Mitral homograft replacement of the tricuspid valve for endocarditis.  Ann Thorac Surg. 1997;  63 1480-1482
• 15 Yankah A C, Sievers H H, Lange P E, Bernhard A. Clinical report on stentless mitral allografts.  J Heart Valve Dis. 1995;  4 40-44
• 16 Mestres C A, Ginel A, Cartana R. Pomar JL. Cryopreserved homografts in aortic and mitral prosthetic endocarditis: expanding the use of biological tissues in complex cardiac infections.  J Heart Valve Dis. 1993;  2 679-683
• 17 Revuelta J M, Bernal J M, Rabasa J M. Transvalvular technique for implantation of a mitral valve homograft.  J Thorac Cardiovasc Surg. 1996;  111 281-282
• 18 Gulbins H, Kreuzer E, Haushofer M, Uhlig A, Reichart B. Homografts for mitral valve replacement in patients with acute endocarditis - an alternative to prosthetic valve replacement.  Z Kardiol. XXXX;  88 363-368
• 19 Goldman M E, Mora F, Guarino T, Fuster V, Mindich B P. Mitral valvuloplasty is superior to valve replacement for preservation of left ventricular function: an intraoperative two-dimensional echocardiography study.  J Am Col Cardiol. 1987;  10 (3) 568-575
• 20 Yun K L, Miller D C. Mitral valve repair versus replacement.  Cardiol Clin. 1991;  9 (2) 315-327
• 21 Graver J M, Cohen C, Weintraub W S. Case-matched comparison of mitral valve replacement and repair.  Ann Thorac Surg. 1990;  49 (6) 964-969
• 22 Tischler M D, Cooper K A, Rowen M, LeWinter M M. Mitral valve replacement versus mitral valve repair. A Doppler and quantitative stress echocardiography study.  Circulation. 1994;  89 (1) 132-137
• 23 Muehrcke D D, Cosgrove D M, Lytle B W. et al . Is there an advantage to repairing infected mitral valves?.  Ann Thorac Surg. 1997;  63 1718-1724
• 24 Pagani F D, Monaghan H L, Deeb G M, Boiling S F. Mitral valve reconstruction for active and healed endocarditis.  Circulation. 1996;  94 11133-11138
• 25 Podesser B K, Rodler S, Hahn R, Eigenbauer E, Vodrazka M, Moritz A, Laufer G, Simon P, Wolner E. Mid-term follow up of mitral valve reconstruction due to active infective endocarditis.  J Heart Valve Dis. 2000;  9 335-340

1 The paper was presented at the 31^st annual meeting of the German Society of Thoracic and Cardiovascular Surgery, Leipzig, 2002.